Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.18 USD | -5.36% | -29.56% | +77.13% |
05-08 | Transcript : Y-mAbs Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
05-07 | Earnings Flash (YMAB) Y-MABS THERAPEUTICS Posts Q1 Revenue $19.9M, vs. Street Est of $22.2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+77.13% | 565M | |
+3.75% | 108B | |
+11.13% | 104B | |
+1.28% | 22.33B | |
-12.86% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.69% | 17.64B | |
+3.64% | 14.05B | |
+37.33% | 12.51B |
- Stock Market
- Equities
- YMAB Stock
- News Y-mAbs Therapeutics, Inc.
- Y-mabs Therapeutics Insider Sold Shares Worth $795,383, According to a Recent SEC Filing